Peculiarities of Abdominal Pain Syndrome in Patients with Functional and Inflammatory Bowel Diseases and Methods of Its Correction

A.E. Dorofeiev, O.A. Rassokhina, Ye.А. Кirian, I.А. Derkach, А.Yu. Butova

Abstract


Objective of this study was to evaluate peculiarities of abdominal pain syndrome in patients with irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) and to assess efficacy of Enterospasmil in complex therapy of these patients. 120 patients with IBS and 35 patients with IBD were examined. Age of patients varied from 18 to 65 years. Abdominal pain syndrome was detected in all patients with IBS and IBD. In examined patients we have detected predominantly variable, without irradiation, often of blunt, aching nature, lasting more than 3 hours, with moderate intensity. Enterospasmil is an effective drug for abdominal pain relief in patients with IBS and IBD and can be used in complex therapy of these patients.

References


Ардатская М.Д. Синдром избыточного бактериального роста: Уч. пос. / М.Д. Ардатская. — М.: Форте принт, 2011. — 56 с.

Клеточные и системные механизмы действия пробиотиков / А.И. Калмыкова, В.Г. Селятицкая, Н.А. Пальчикова [и др.]. — Новосибирск, 2007. — 280 с.

Ткаченко Е.И. Дисбиоз кишечника. Руководство по диагностике и лечению / Е.И. Ткаченко, А.Н. Суворова. — СПб.: Спецлит, 2007. — 238 с.

Bixquert Jimûnez Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last? / Bixquert Jimûnez // Rev. Esp. Enfem. Dig. — 2009. — Vol. 101, № 8. — P. 553-564.

Collins S.M. The interplay between the intestinal microbiota and the brain / S.M. Collins, M. Surette, P. Bercik // Nature Reviews Microbiology. — 2012. — Vol. 10. — P. 735-742.

Identification of the early VIP-regulated transcriptome and its associated, interactome in resting and activated murine CD4 T cells / S.T. Dorsam, E. Vomhof-DeKrey, R.J. Hermann [et al.] // Molecular Immunology. — 2010. — Vol. 47, № 6. — P. 1181-1194.

A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome / Drouault, S. Holowacs, S. Bieuvelet [et al.] // Gastroenterol. Clin. Biol. — 2008. — Vol. 32, № 2. — P. 147-152.

WGO Practice Guideline — Irritable Bowel Syndrome: a global perspective / Q. Eamon [et al.]. — World Gastroenterology Organisation, 2009.

Adoptive transfer of macrophage from mice with depression-like behavior enhances susceptibility to colitis / J.E. Ghia, A.J. Park, P. Blennerhassett [et al.] // Inflammatory Bowel Di-seases. — Vol. 17, № 7. — Р. 1474-1489.

Correlation of gut hormones with irritable bowel syndrome / H. Zhang Y. Yan, R. Shi [et al.] // Digestion. — 2008. — Vol. 78, № 2–3. — P. 72-76.




DOI: https://doi.org/10.22141/2308-2097.4.54.2014.82083

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 GASTROENTEROLOGY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru